Endogenous enkephalins and reward mechanisms
内源性脑啡肽和奖励机制
基本信息
- 批准号:10203896
- 负责人:
- 金额:$ 30.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAddressAffectAffinityAmericanBehaviorBehavioralBehavioral MechanismsBindingBrainChronicChronic DiseaseCocaineCocaine DependenceComplexCorpus striatum structureCuesDataDevelopmentDopamineDrug AddictionDrug ControlsEnkephalinsFemaleFutureGlutamatesGoalsHealthKnowledgeLeadLearningLifeLigandsMass Spectrum AnalysisMeasurementMediatingMediator of activation proteinMicrodialysisMissionMotivationNeurobiologyNeurotransmittersNucleus AccumbensOpioidPathway interactionsPharmaceutical PreparationsPharmacologyPlayProceduresProcessPropertyPsychological reinforcementReceptor ActivationReceptor SignalingRelapseReportingResearchRewardsRoleSamplingSex DifferencesSiteSocietiesStimulusSystemTechniquesTimeUnited States National Institutes of HealthWood materialWorkaddictionbasebehavior measurementdelta opioid receptordesigndrug cravingdrug developmentdrug of abusedrug relapseendogenous opioidsexperimental studyin vivoinnovationknock-downmaleneural circuitneurobiological mechanismneurochemistrynovelpaired stimulipleasurepreventreinforcerresponsesmall hairpin RNA
项目摘要
Project Summary/Abstract
There are fundamental gaps in our understanding of the neurobiological processes involved in addiction, in
particular the complex changes produced by drug-paired cues (conditioned reinforcers) that increase drug-taking
behavior and provoke relapse. Identifying novel mechanisms by which conditioned reinforcers modify behavior
is essential for future efforts to design new treatments to control drug craving and prevent relapse to addiction.
The long-term goal of this work is to further our understanding of the behavioral and neurobiological mechanisms
mediating drug-paired stimuli that serve as conditioned reinforcers. The objective of this application is to identify
the role of the endogenous enkephalinergic system in regulating the reinforcing properties of cocaine-associated
stimuli that are an essential part of cocaine addiction. Enkephalins binds with high affinity to delta-opioid
receptors (DOPRs), which are highly expressed within the reward pathway, and DOPR activation can alter
responding for drug-paired cues without primary reinforcing effects. Our overarching hypothesis is that
enkephalins acting at delta-opioid receptors (DOPRs) in the nucleus accumbens shell (NAc-S) play an essential
role in the behavioral and neurochemical mechanisms mediating the conditioned reinforcing properties of
cocaine-paired cues. This proposal will couple behavioral measurements of conditioned reinforcement with in
vivo microdialysis and comprehensive mass spectrometry analysis to evaluate in real-time the role of the
enkephalin and DOPRs in establishing and maintaining the salience of cocaine-associated cues. Through the
innovative use of behavioral and neurochemical measurement techniques, this proposal will expand beyond the
status quo to investigate novel mechanisms selectively mediating conditioned reinforcement but not necessarily
the direct, primary reinforcing effects of cocaine. Ultimately, such knowledge has the potential to develop new
treatments for preventing relapse.
项目概要/摘要
我们对成瘾所涉及的神经生物学过程的理解存在根本性的差距,
特别是由增加吸毒的药物配对线索(条件强化物)产生的复杂变化
行为并引发复发。识别条件强化物改变行为的新机制
对于未来设计新疗法来控制毒瘾和防止毒瘾复发至关重要。
这项工作的长期目标是进一步了解行为和神经生物学机制
介导作为条件强化物的药物配对刺激。该应用程序的目的是识别
内源性脑啡肽能系统在调节可卡因相关增强特性中的作用
刺激是可卡因成瘾的重要组成部分。脑啡肽与 δ-阿片类药物具有高亲和力
受体(DOPR),在奖赏途径中高度表达,DOPR 激活可以改变
对药物配对的线索做出反应,而没有主要的强化作用。我们的总体假设是
作用于伏隔核壳 (NAc-S) 中 δ-阿片受体 (DOPR) 的脑啡肽发挥着重要作用
在介导条件强化特性的行为和神经化学机制中的作用
可卡因配对线索。该提案将把条件强化的行为测量与in
体内微透析和综合质谱分析实时评估
脑啡肽和 DOPR 建立和维持可卡因相关线索的显着性。通过
行为和神经化学测量技术的创新使用,该提案将扩展到
现状研究选择性介导条件强化的新机制,但不一定
可卡因的直接、主要的强化作用。最终,这些知识有可能开发出新的知识
预防复发的治疗。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EMILY M JUTKIEWICZ其他文献
EMILY M JUTKIEWICZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EMILY M JUTKIEWICZ', 18)}}的其他基金
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10221663 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10159424 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10026089 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10672930 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
9894965 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10449233 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10448677 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Abuse potential of a novel bifunctional opioid ligand
新型双功能阿片类配体的滥用潜力
- 批准号:
9245248 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
Abuse potential of a novel bifunctional opioid ligand
新型双功能阿片类配体的滥用潜力
- 批准号:
9419813 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The effect of aging on neurotransmitters and motor performance in a primate model
衰老对灵长类动物模型中神经递质和运动表现的影响
- 批准号:
10573386 - 财政年份:2023
- 资助金额:
$ 30.67万 - 项目类别:
Neural mechanisms of ASH1L in autism spectrum disorder
ASH1L 在自闭症谱系障碍中的神经机制
- 批准号:
10725205 - 财政年份:2023
- 资助金额:
$ 30.67万 - 项目类别:
The impact of a neonicotinoid pesticide on neural functions underlying learning and memory
新烟碱类农药对学习和记忆神经功能的影响
- 批准号:
10646631 - 财政年份:2023
- 资助金额:
$ 30.67万 - 项目类别:
Peptibodies As Novel Therapies in Atrial Fibrillation
肽体作为心房颤动的新疗法
- 批准号:
10598711 - 财政年份:2023
- 资助金额:
$ 30.67万 - 项目类别:
Optogenetic and chemogenetic regulation of uterine vascular function
子宫血管功能的光遗传学和化学遗传学调控
- 批准号:
10785667 - 财政年份:2023
- 资助金额:
$ 30.67万 - 项目类别: